Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CAMT · Nasdaq · United States · Optical Instruments & Lenses
In shortCAMTEK LTD is profitable, generates cash and carries moderate debt, with revenue growing (+15.6% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 25.8% | 100/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 10.2% | 61/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 8.7% | 43/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 10.9% | 73/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 8.35× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.84× | 64/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.88× | 61/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 6.80 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 25.7% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 2.51× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 28.3% | 6/100 |
| Operating margin volatility | 2.2% | 89/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 15.6% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | -14.8% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 270 | 321 | 315 | 429 | 496 |
| Cost of revenue | 132 | 161 | 168 | 219 | 246 |
| Gross profit | 137 | 160 | 148 | 210 | 250 |
| Research & development | 23 | 29 | 31 | 38 | 48 |
| Selling, general & admin | 43 | 49 | 51 | 64 | 74 |
| Operating income | 71 | 81 | 65 | 108 | 128 |
| Pre-tax income | 72 | 88 | 88 | 131 | 52 |
| Income tax | 12 | 8.2 | 9 | 13 | 1.6 |
| Net income | 60 | 80 | 79 | 119 | 51 |
| Diluted EPS | $1.34 | $1.68 | $1.63 | $2.42 | $1.04 |
| Diluted shares (millions) | 0 | 0 | 0 | 0 | 0 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
6.80 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 19, 2026